[Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D007052:Ibuprofen / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010974:Platelet Aggregation / Q000187:drug effects*; D011449:Prostaglandin Endoperoxides / Q000378:metabolism*; D011463:Prostaglandins H / Q000378:metabolism*; D011817:Rabbits; D013928:Thromboxane A2 / Q000096:biosynthesis*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D013931:Thromboxanes / Q000096:biosynthesis*
D000925:Anticoagulants; D016861:Cyclooxygenase Inhibitors; D007093:Imidazoles; D009097:Multienzyme Complexes; D011449:Prostaglandin Endoperoxides; D011463:Prostaglandins H; D013931:Thromboxanes; D013928:Thromboxane A2; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase; D007052:Ibuprofen
Podavlenie agregatsii trombotsitov kak rezul'tat dvukhkomponentnogo ingibirovaniia polifermentnoĭ sistemy sinteza tromboksana.